Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1996 Sep 1;318(Pt 2):389–393. doi: 10.1042/bj3180389

Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection.

T Suzuki 1, A Sometani 1, Y Yamazaki 1, G Horiike 1, Y Mizutani 1, H Masuda 1, M Yamada 1, H Tahara 1, G Xu 1, D Miyamoto 1, N Oku 1, S Okada 1, M Kiso 1, A Hasegawa 1, T Ito 1, Y Kawaoka 1, Y Suzuki 1
PMCID: PMC1217634  PMID: 8809024

Abstract

We found, by using a virus overlay assay, that influenza A virus isolates bind to sulphatide (HSO3-Gal beta 1-->1'Cer), which has no sialic acid residue, and that the infection of Madin-Darby canine kidney cells with the human influenza virus A/Memphis/1/71 (H3N2) is inhibited by sulphatide. A/Memphis/1/71 (H3N2) causes obvious haemagglutination and low-pH haemolysis of asialoerythrocytes reconstituted with sulphatide. All influenza A virus isolates from the species of animals so far tested bound to sulphatide. The sulphatide-binding specificity of the isolates was different from the viral sialyl-linkage specificity. Influenza A virus isolates also bound to galactosyl ceramide (GalCer; Gal beta 1-->1'Cer), as well as sulphatide, in the virus overlay assays. In contrast, the influenza virus did not bind to N-deacyl, a derivative of sulphatide, glucosyl ceramide or the other neutral glycolipids tested. These results indicate that the linkage of galactose, or sulphated galactose, to ceramide is important for viral binding.

Full Text

The Full Text of this article is available as a PDF (418.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain C. C., Henson C. P., Nadel M. K., Knoblesdorff A. J. Rapid single-step kinetic colorimetric assay for lactate dehydrogenase in serum. Clin Chem. 1973 Feb;19(2):223–227. [PubMed] [Google Scholar]
  2. Bhat S., Spitalnik S. L., Gonzalez-Scarano F., Silberberg D. H. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7131–7134. doi: 10.1073/pnas.88.16.7131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown K. E., Anderson S. M., Young N. S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993 Oct 1;262(5130):114–117. doi: 10.1126/science.8211117. [DOI] [PubMed] [Google Scholar]
  4. Carroll S. M., Higa H. H., Paulson J. C. Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins. J Biol Chem. 1981 Aug 25;256(16):8357–8363. [PubMed] [Google Scholar]
  5. Chien J. L., Li S. C., Li Y. T. Isolation and characterization of a heptaglycosylceramide from bovine erythrocyte membranes. J Lipid Res. 1979 Jul;20(5):669–673. [PubMed] [Google Scholar]
  6. Clarke J. T., Wolfe L. S., Perlin A. S. Evidence for a terminal -D-galactopyranosyl residue in galactosylgalactosylglucosylceramide from human kidney. J Biol Chem. 1971 Sep 25;246(18):5563–5569. [PubMed] [Google Scholar]
  7. Connor R. J., Kawaoka Y., Webster R. G., Paulson J. C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology. 1994 Nov 15;205(1):17–23. doi: 10.1006/viro.1994.1615. [DOI] [PubMed] [Google Scholar]
  8. Conyers S. M., Kidwell D. A. Chromogenic substrates for horseradish peroxidase. Anal Biochem. 1991 Jan;192(1):207–211. doi: 10.1016/0003-2697(91)90208-b. [DOI] [PubMed] [Google Scholar]
  9. Fantini J., Cook D. G., Nathanson N., Spitalnik S. L., Gonzalez-Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2700–2704. doi: 10.1073/pnas.90.7.2700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Haataja S., Tikkanen K., Liukkonen J., François-Gerard C., Finne J. Characterization of a novel bacterial adhesion specificity of Streptococcus suis recognizing blood group P receptor oligosaccharides. J Biol Chem. 1993 Feb 25;268(6):4311–4317. [PubMed] [Google Scholar]
  11. Kameyama A., Ishida H., Kiso M., Hasegawa A. Stereoselective synthesis of sialyl-lactotetraosylceramide and sialylneolactotetraosylceramide. Carbohydr Res. 1990 Apr 25;200:269–285. doi: 10.1016/0008-6215(90)84197-3. [DOI] [PubMed] [Google Scholar]
  12. Manuguerra J. C., DuBois C., Hannoun C. Analytical detection of 9(4)-O-acetylated sialoglycoproteins and gangliosides using influenza C virus. Anal Biochem. 1991 May 1;194(2):425–432. doi: 10.1016/0003-2697(91)90252-O. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Prasadarao N. V., Wass C. A., Hacker J., Jann K., Kim K. S. Adhesion of S-fimbriated Escherichia coli to brain glycolipids mediated by sfaA gene-encoded protein of S-fimbriae. J Biol Chem. 1993 May 15;268(14):10356–10363. [PubMed] [Google Scholar]
  14. Rogers G. N., Daniels R. S., Skehel J. J., Wiley D. C., Wang X. F., Higa H. H., Paulson J. C. Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. J Biol Chem. 1985 Jun 25;260(12):7362–7367. [PubMed] [Google Scholar]
  15. Rogers G. N., Paulson J. C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology. 1983 Jun;127(2):361–373. doi: 10.1016/0042-6822(83)90150-2. [DOI] [PubMed] [Google Scholar]
  16. Srnka C. A., Tiemeyer M., Gilbert J. H., Moreland M., Schweingruber H., de Lappe B. W., James P. G., Gant T., Willoughby R. E., Yolken R. H. Cell surface ligands for rotavirus: mouse intestinal glycolipids and synthetic carbohydrate analogs. Virology. 1992 Oct;190(2):794–805. doi: 10.1016/0042-6822(92)90917-e. [DOI] [PubMed] [Google Scholar]
  17. Suzuki T., Harada M., Suzuki Y., Matsumoto M. Incorporation of sialoglycoprotein containing lacto-series oligosaccharides into chicken asialoerythrocyte membranes and restoration of receptor activity toward hemagglutinating virus of Japan (Sendai virus). J Biochem. 1984 Apr;95(4):1193–1200. doi: 10.1093/oxfordjournals.jbchem.a134709. [DOI] [PubMed] [Google Scholar]
  18. Suzuki T., Jyono M., Tsukimoto M., Hamaoka A., Suzuki Y. Labeling of influenza virus with alkylamine-modified horseradish peroxidase. Anal Biochem. 1995 Jun 10;228(1):42–47. doi: 10.1006/abio.1995.1312. [DOI] [PubMed] [Google Scholar]
  19. Suzuki Y., Kato H., Naeve C. W., Webster R. G. Single-amino-acid substitution in an antigenic site of influenza virus hemagglutinin can alter the specificity of binding to cell membrane-associated gangliosides. J Virol. 1989 Oct;63(10):4298–4302. doi: 10.1128/jvi.63.10.4298-4302.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Suzuki Y., Matsunaga M., Matsumoto M. N-Acetylneuraminyllactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption-fusion process of viral infection. Binding specificity of influenza virus A/Aichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid. J Biol Chem. 1985 Feb 10;260(3):1362–1365. [PubMed] [Google Scholar]
  21. Suzuki Y., Nagao Y., Kato H., Matsumoto M., Nerome K., Nakajima K., Nobusawa E. Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached. J Biol Chem. 1986 Dec 25;261(36):17057–17061. [PubMed] [Google Scholar]
  22. Suzuki Y., Nagao Y., Kato H., Suzuki T., Matsumoto M., Murayama J. The hemagglutinins of the human influenza viruses A and B recognize different receptor microdomains. Biochim Biophys Acta. 1987 Oct 16;903(3):417–424. doi: 10.1016/0005-2736(87)90048-4. [DOI] [PubMed] [Google Scholar]
  23. Suzuki Y., Nakao T., Ito T., Watanabe N., Toda Y., Xu G., Suzuki T., Kobayashi T., Kimura Y., Yamada A. Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains. Virology. 1992 Jul;189(1):121–131. doi: 10.1016/0042-6822(92)90687-k. [DOI] [PubMed] [Google Scholar]
  24. Suzuki Y., Suzuki T., Matsunaga M., Matsumoto M. Gangliosides as paramyxovirus receptor. Structural requirement of sialo-oligosaccharides in receptors for hemagglutinating virus of Japan (Sendai virus) and Newcastle disease virus. J Biochem. 1985 Apr;97(4):1189–1199. doi: 10.1093/oxfordjournals.jbchem.a135164. [DOI] [PubMed] [Google Scholar]
  25. Suzuki Y., Toda Y., Tamatani T., Watanabe T., Suzuki T., Nakao T., Murase K., Kiso M., Hasegawa A., Tadano-Aritomi K. Sulfated glycolipids are ligands for a lymphocyte homing receptor, L-selectin (LECAM-1), Binding epitope in sulfated sugar chain. Biochem Biophys Res Commun. 1993 Jan 29;190(2):426–434. doi: 10.1006/bbrc.1993.1065. [DOI] [PubMed] [Google Scholar]
  26. Watanabe W., Sudo K., Asawa S., Konno K., Yokota T., Shigeta S. Use of lactate dehydrogenase to evaluate the anti-viral activity against influenza A virus. J Virol Methods. 1995 Feb;51(2-3):185–191. doi: 10.1016/0166-0934(94)00103-n. [DOI] [PubMed] [Google Scholar]
  27. Yahi N., Baghdiguian S., Moreau H., Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J Virol. 1992 Aug;66(8):4848–4854. doi: 10.1128/jvi.66.8.4848-4854.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zimmer G., Reuter G., Schauer R. Use of influenza C virus for detection of 9-O-acetylated sialic acids on immobilized glycoconjugates by esterase activity. Eur J Biochem. 1992 Feb 15;204(1):209–215. doi: 10.1111/j.1432-1033.1992.tb16626.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES